This week in the news, the University of Michigan receives a grant for dry AMD research, protocols can improve intravitreal injection safety, and asynchronous teleophthalmology is embraced by patients with glaucoma. Source: AAO
Vitrectomy combined with scleral buckle achieved results superior to vitrectomy alone in the treatment of rhegmatogenous retinal detachment with vitreous hemorrhage. Source: AAO
This multicenter registry study showed no differences in graft failure or rejection rates for patients with Fuchs dystrophy undergoing DSAEK who received gender or H-Y matched donor corneas compared to patients with mismatched donor corneas. Source: AAO
The risk of cardiovascular and cerebrovascular disease significantly increased for COVID-19 patients during the 12 months following their positive test. Source: AAO
A study shows greater improvement in visual acuity with internal limiting membrane (ILM) peeling vs. the inverted ILM flap technique to repair idiopathic macular holes. Source: AAO
This study identified anterior segment OCT biometric parameters that are risk factors for progression from primary angle-closure suspect to more severe disease. Source: AAO
This study evaluated the efficacy and safety outcomes of eyes with neurotrophic keratitis (NK) that underwent a course of cenegermin-bkbj (Oxervate) in the presence of a bandage contact lens (BCL). Source: AAO
This week in the news, erectile dysfunction (ED) drugs can have serious ocular effects, a new trial is assessing diabetic macular edema (DME) in underserved populations, and more retinal vein occlusions are seen after COVID-19 diagnosis. Source: AAO
Results from the phase 3 ADAPT trial of the efficacy and safety of efgartigimod in patients with generalized myasthenia gravis (MG) are now available. Source: AAO
Both current patient data and cases reported in the literature were assessed to ascertain the frequency and presentation of myasthenia gravis in the setting of immune checkpoint inhibitor therapy. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »